Trials / Completed
CompletedNCT02199080
D-dimer Assay for the Exclusion of Intra-atrial Thrombus Risk Before Ablation of Atrial Fibrillation
Etude du Dosage Des d-dimères sériques Pour le Diagnostic d'Exclusion Des Thrombi Intra-atriaux Avant Ablation Endocavitaire de Fibrillation Atriale
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,506 (actual)
- Sponsor
- Groupe Hospitalier de la Rochelle Ré Aunis · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether D-dimer dosage allow to exclude risk of intraatrial thrombus before performing an ablation of atrial fibrillation
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | D-dimer assay before ablation of atrial fibrillation | Blood sample collection for D-dimers measurement |
Timeline
- Start date
- 2014-07-28
- Primary completion
- 2016-01-01
- Completion
- 2016-05-01
- First posted
- 2014-07-24
- Last updated
- 2023-10-30
- Results posted
- 2019-02-15
Locations
37 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02199080. Inclusion in this directory is not an endorsement.